We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Protein Binding Controls Formation of Blood Clots

By Biotechdaily staff writers
Posted on 10 Jun 2002
Researchers used laser tweezers to measure the regulation of forces between individual ligand-receptor pairs on living cells in blood platelets, where the strength of the bond between a single integrin molecule on the surface of the platelet and a molecule of fibrinogen was determined. More...
This study, which adds important information as to how blood clots form, was published in the May 28, 2002, issue of the Proceedings of the National Academy of Sciences.

"Laser tweezers use the force of a focused laser beam to trap and move particles. In this case, we used the tweezers to play tug-of-war with a platelet-bound integrin molecule on one side and a fibrinogen molecule mounted on a tiny latex bead on the other,” explained Dr. John W. Weisel, of the University of Pennsylvania (Philadelphia, USA) and one of the authors. "We were able to measure the force that keeps blood clots together. We can also determine the regulation of forces between individual ligand-receptor pairs and the effects of anticlotting drugs, at the single molecule level.”

Platelets are activated and change shape after receiving chemical signals from damaged blood vessel cells. The platelets change shape and expose approximately 80,000 copies of the alpha IIb beta 3 integrin protein. Each of these copies binds to fibrinogen, a fibrous protein that binds the platelets together to form a clot. Clotting is vitally important to control bleeding, but inappropriate formation of a clot can lead to heart attack or stroke.

The investigators developed a new model system using tiny pedestals and beads that could be trapped and moved in order to use laser tweezers to measure the strength of a single bond between protein molecules. They attached fibrinogen to microscopic plastic beads and exposed them to integrin that was either attached to pedestals or in situ on the surface of living, reactive platelet cells. Measurements showed that the rupture forces of individual fibrinogen molecules and purified integrin on the surface of living platelets were 60 to 150 pN (picoNewtons) with peak yield strength of 80-100 pN.

"Platelets are like multiple-watt lightbulbs: they can be turned on to different degrees of activation,” said Dr. Weisel. "Interestingly, our findings suggest that no matter which setting you turn a platelet to, integrin binds to fibrinogen with the same affinity.”



Related Links:
University of Pennsylvania

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Urine Analyzer
respons® UDS100
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.